BeiGene Ltd. (BGNE)
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 9:00 PM
BeiGene Ltd. Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 2.46B | 1.42B | 1.18B | 308.87M | 428.21M | 198.22M | 238.39M | 1.07M | 8.82M | 13.04M | 11.15M |
| Cost of Revenue | 379.92M | 1.93B | 1.62B | 1.37B | 998.53M | 707.71M | 273.99M | 98.03M | 58.25M | 21.86M | 13.46M |
| Gross Profit | 2.08B | -511.06M | -447.86M | -1.06B | -570.32M | -509.49M | -35.6M | -96.96M | -49.43M | -8.83M | -2.31M |
| Operating Income | -1.21B | -1.79B | -1.44B | -1.66B | -959.89M | -705.77M | -98.46M | -117.06M | -56.74M | -15.76M | -5.46M |
| Interest Income | n/a | 74.18M | 13.51M | 2M | 9.13M | n/a | n/a | n/a | 1.79M | 40K | 2K |
| Pretax Income | -825.84M | -1.96B | -1.44B | -1.62B | -943.59M | -689.83M | -91.06M | -119.16M | -57.1M | -18.55M | -7.89M |
| Net Income | -881.71M | -2B | -1.41B | -1.6B | -950.58M | -673.77M | -93.11M | -119.22M | -57.1M | -18.28M | -7.49M |
| Selling & General & Admin | 1.5B | 1.28B | 990.12M | 600.18M | 388.25M | 195.38M | 62.6M | 20.1M | 7.31M | 6.93M | 3.14M |
| Research & Development | 1.78B | 1.64B | 1.46B | 1.29B | 927.34M | 679M | 269.02M | 98.03M | 58.25B | 21.86M | 13.46M |
| Other Expenses | 3.5M | -1.64B | 750K | 846K | 1.33M | 894K | 250K | -2.49M | -916K | 600K | 584K |
| Operating Expenses | 3.29B | 1.28B | 990.87M | 601.02M | 389.57M | 196.28M | 62.85M | 20.1M | 7.31M | 6.93M | 3.14M |
| Interest Expense | n/a | 52.48M | n/a | 338K | 9.13M | 13.95M | n/a | 383K | 1.23M | 3.55M | 3.15M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 3.67B | 3.21B | 2.62B | 1.97B | 1.39B | 903.99M | 336.84M | 118.13M | 65.56M | 28.79M | 16.61M |
| Income Tax | 55.87M | 42.78M | -25.23M | -17.67M | 6.99M | -15.8M | 2.23M | 54K | 872K | 763K | 719K |
| Shares Outstanding (Basic) | 104.39M | 103.13M | 92.79M | 83.47M | 60.05M | 55.44M | 45.54M | 39.68M | 31.52M | 52.66M | 52.66M |
| Shares Outstanding (Diluted) | 104.39M | 103.13M | 92.79M | 83.47M | 60.05M | 55.44M | 45.54M | 39.68M | 31.52M | 52.66M | 52.66M |
| EPS (Basic) | -8.45 | -19.43 | -15.23 | -19.17 | -15.83 | -12.15 | -2.04 | -3 | -1.81 | -0.35 | -0.14 |
| EPS (Diluted) | -8.45 | -19.43 | -15.23 | -19.17 | -15.83 | -12.15 | -2.04 | -3 | -1.81 | -0.35 | -0.14 |
| EBITDA | -1.12B | -1.73B | -1.39B | -1.63B | -941.27M | -695.38M | -93.7M | -115.15M | -55.2M | -14.2M | -3.15M |
| Depreciation & Amortization | 87.67M | 66.28M | 46.46M | 31.79M | 18.62M | 9.89M | 4.59M | 1.91M | 1.54M | 1.56M | 1.59M |